OCT 06, 2021 12:00 PM PDT

Panel Presentation: Luminex Imaging and Flow Cytometry in Immuno-Oncology

Sponsored by: LUMINEX
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract

Advancements in immuno-oncology have been moving at an ever-quickening pace. From the development of new CAR-T therapies to a better understanding of the mechanism of action of monoclonal antibody treatments, the field has advanced through diligent research supported by technologies that enable scientists to make new discoveries. One critical technology that helps advance this research is imaging flow cytometry (IFC). In this seminar, we will briefly describe the Amnis® ImageStream®X Mk II IFC system and highlight how it can synergize with other techniques as an orthogonal method to validate scientific observations. We will describe some of the core applications that have been greatly enhanced by IFC, including how images can be used to measure T cell activation after binding antigen-presenting cells (APCs), quantify immune synapse formation, characterize CRISPR/CAS9-edited CAR-T cells in finding target cells, and use cell morphology to identify cell death from chemotherapeutic agents. We will also show more traditional flow cytometry approaches to cellular-based assays, including accurate count and viability determination of peripheral blood mononuclear cells (PBMCs), characterization of cellular subsets, and dissection of naïve and memory sub-populations using our Guava® and CellStream® technologies. Examples of multiparametric cellular health assays and their insights in the cellular response will also be discussed. Lastly, we will explain how using the CellStream® to identify circulating extracellular vesicles enables the identification of a known biomarker for certain malignancies.

Learning Objectives:

1. Demonstrate the utility of using imaging flow cytometry to gain a better understanding of how immune cells are used in oncology research.

2. Explain the advantages of using microcapillary flow in absolute counting of Blood/PBMC evaluations.

3. Discuss using flow cytometry to gain insights into how extracellular vesicles are involved in cancer communication.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
NOV 18, 2021 8:00 AM PST
C.E. CREDITS
NOV 18, 2021 8:00 AM PST
Date: November 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Keep ahead in CAR T and CAR NK cell research. We introduce advanced techniques for generating and characterizing engineered immune c...
Loading Comments...
Show Resources